Pepper Bio hopes to challenge Eroom’s law with new funding

Whether you are a tech optimist or not, you have to acknowledge that progress rarely follows a straight line. While the world keeps getting better at churning semiconductors, we are still struggling to find new drugs to treat resistant diseases, and the process isn’t getting cheaper. Some hope that AI can help, and it likely will — when it comes to biotech, it is much more than a buzzword.  But Boston-based drug discovery…

Comments Off on Pepper Bio hopes to challenge Eroom’s law with new funding

Pepper wins $6.5m to develop ‘transomics’ drug discovery platform

Pepper’s Compass platform offers insight into the real-time function of proteins, which can help in drug discovery. Boston-based start-up Pepper Bio has raised $6.5m in oversubscribed seed funding to develop its Compass drug discovery platform. The financiers included venture capital companies such as NFX, Silverton Partners, Mana Ventures and others. Pepper’s CEO Jon Hu told Pharmaceutical Technology that the Compass platform provides biological maps for insight into different “-omics”- genomics, transcriptomics, proteomics…

Comments Off on Pepper wins $6.5m to develop ‘transomics’ drug discovery platform

Pepper Bio, the ’Google Maps for Drug Discovery’, Secures $6.5M to Streamline R&D

What You Should Know: Pepper Bio, the “Google Maps for drug discovery,” today announced an oversubscribed $6.5 million seed round led by NFX with participation from Silverton Partners, Merck Digital Sciences Studio, Mana Ventures, Tensility Ventures, VSC Ventures, and more. Pepper Bio is the world’s first transomics company, which maps data across all the -omics layers and translates it into the fastest route for discovering new drugs, finding new uses for existing therapeutics,…

Comments Off on Pepper Bio, the ’Google Maps for Drug Discovery’, Secures $6.5M to Streamline R&D

Overcoming EGFRi Resistance Through Transomic Analyses

Pepper Bio is on a mission to put an end to untreatable diseases by enabling more effective drug discovery through the use of transomic analysis. We do this using our COMPASS platform that integrates data across the genomic, transcriptomic, proteomic, and phosphoproteomic biological layers to uncover global, functional and causal understanding of complex biological processes. At the 2023 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference, hosted by the American Association…

Comments Off on Overcoming EGFRi Resistance Through Transomic Analyses

Podcast: Unlocking the Potential of Transomics in Biotech

In this enlightening episode, the Artificial Intelligence podcast sat down with Samantha Dale Strasser, the co-founder and CSO of Pepper Bio, a pioneering company in the world of transomics drug discovery. Discover the vital role of phosphoproteomic data, the challenges and innovations in integrating multiple -omics layers, and how AI is set to revolutionize clinical trials and drug discovery. Join us on this journey as we explore the foundation of…

Comments Off on Podcast: Unlocking the Potential of Transomics in Biotech

Podcast: Using Transomics In Drug Discovery

Samantha Dale Strasser is the Chief Science Officer and co-founder of Pepper Bio. Pepper Bio is the world's first transomics analysis company. Transomics involves analyzing a wealth of biological information from genomics all the way up to more functional data of phosphoproteomics. Pepper Bio is able to see more relevant disease insights about how to best treat disease and how to characterize potential drugs that can be used as therapeutics.…

Comments Off on Podcast: Using Transomics In Drug Discovery